CORRECT: Arcontech profit and sales fall; Kromek profit tops forecast
(Corrects the financial 2026 gross margin figure for Fusion Antibodies PLC to 58.3%.) Read More
| Price | 1.70p on 14-10-2026 at 17:35:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 1.80p |
| Sell | 1.60p |
| Last Trade: | Buy 89,855.00 at 1.735p |
| Day's Volume: | 510,451 |
| Last Close: | 1.70p |
| Open: | 1.70p |
| ISIN: | GB00B03CJS30 |
| Day's Range | 1.70p - 1.70p |
| 52wk Range: | 1.15p - 2.30p |
| Market Capitalisation: | £22.38m |
| VWAP: | 1.720558p |
| Shares in Issue: | 1.32b |
Sector: Fossil Fuels
Listed In: FTSE AIM All-Share,
Europa Oil & Gas (EOG) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 89,855 | 1.735p | Ordinary |
15:56:19 - 14-Oct-26 |
| Sell* | 182,500 | 1.68p | Ordinary |
12:12:34 - 14-Oct-26 |
| Buy* | 143,266 | 1.745p | Ordinary |
12:03:48 - 14-Oct-26 |
| Buy* | 38,000 | 1.748p | Ordinary |
08:25:35 - 14-Oct-26 |
| Buy* | 56,810 | 1.748p | Ordinary |
08:04:49 - 14-Oct-26 |
| Buy* | 20 | 1.748p | Ordinary |
08:01:33 - 14-Oct-26 |
| Buy* | 50,000 | 1.748p | Ordinary |
16:08:47 - 13-Oct-26 |
| Buy* | 188,571 | 1.75p | Ordinary |
15:28:44 - 13-Oct-26 |
| Sell* | 190 | 1.6752p | Ordinary |
15:21:50 - 13-Oct-26 |
| Sell* | 12,500 | 1.68p | Ordinary |
14:32:12 - 13-Oct-26 |
Europa Oil & Gas (EOG) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Sep 2026 7:00 am | RNS | Update on EG-08 Farm-out Agreement |
| 14th Sep 2026 7:00 am | RNS | Interim Results |
| 1st Sep 2026 7:00 am | RNS | Update on EG-08 Farm-out Agreement |
| 31st Jul 2026 12:05 pm | RNS | Holding(s) in Company |
| 31st Jul 2026 7:00 am | RNS | Update on EG-08 Farm-out Agreement |
| 29th Jul 2026 7:00 am | RNS | Exercise of Options and Total Voting Rights |
| 9th Jul 2026 9:29 am | RNS | Block Listing Application to AIM |
| 29th Jun 2026 1:10 pm | RNS | Result of AGM |
| 26th Jun 2026 7:00 am | RNS | Appointment of Nominated Adviser and Broker |
| 22nd Jun 2026 9:21 am | RNS | Director/PDMR Shareholding |